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Mucous Membrane of Respiratory
Epithelium
by Lynne M. Reid* and Rosemary Jones*
Oftheeight epithelial cell typesofthe airway surfaceepithelium three aresecretory, the mucous, serous
andClaracells: thefirsttwoarealsofound inthesubmucosalglands. Organcultureresultsindicatethatthe
patternofcontrolofthesurface cellsisdifferentfromthatoftheglands. Ourrecentstudiesshowthatinthe
surfaceepitheliumClaraandserouscellscanquicklyconverttomucousasdononsecretoryundifferentiated
cells. The balance between the various cell types changes with airway level.
The type ofglycoprotein withinthe secretory granules is neutral oracid, sialylated or sulfated, and also
showsaregional pattern. Homeostasisismaintained inthenormal buttheequilibriumisquicklyupsetbya
variety of irritants, infection or drugs. Change in pattern of glycoprotein synthesis depends largely on
change ofgranules. The granules at the cell apex change first. The nature and distribution ofthe various
receptor binding sites is significant in patterns ofcontrol. This lability occurs in an intact epithelium and
whether or not mitotic activity is increased. With irritation tolerance to stimulus develops. Anti-
inflammatory agents can protect against some ofthese cellularand intracellularevents. Our organculture
studies and biochemical analysis of secretion complement the tissue studies.
Recent studies show that isoproterenol and salbutamol (a nonselective ,B agonist and a selective (2,
respectively) alterthenormalmixofcelltypesandquickly, butthattheyhavedifferentregionalspecificity.
Although there are animal models in which the
airway damage is associated with necrosis and
sloughing ofepithelium, this report concentrates on
animal models in which the nature and dose of the
damaging agent are such that the epithelium remains
intact. Such models are especially relevanttounder-
standingthe effectofarelatively lowdoseofirritants
whether delivered in acute orchronic exposure. It is
a remodelling of the cell population of the normal
intact epithelium that occurs, one that is particularly
related to mucus hypersecretion, doubtless the most
obvious single feature of the response and almost
certainly the most important functionally (1, 2).
Even when the injury is serious enough to cause
ulceration we have shown healing occurs while the
administration of the irritant continues and in the
new epithelium a similar remodelling is seen to that
discussed below (3). Our most recent studies show
that changes that we identify with chronic irritation
occur quickly, much more quickly than previously
suspected (4, 5).
In such studies it is essential to use animals with
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"clean" lungs (6, 7). The normal human airways are
sterile, and even with mucus hypersecretion this
state often continues. We find that histological
criteria are more sensitive to determine satisfactory
cleanness than bacteriological or viral studies. Lym-
phocyte infiltration may be of an unacceptable de-
gree even when the lungs are sterile.
The mixed nature of the mucus or total bronchial
liquid, and the variety ofepithelial cells responsible
for the special mucus or epithelial glycoproteins
(8-10) call for a multidisciplinary approach. Animal
models orin vivo studies with which we are particu-
larly concerned here can be complemented by in
vitro studies ofthe tissue cells. (11-13). Histochemi-
cal studies (14-19) are complemented bybiochemical
analysis of total secretion, both its broncial and
serum components (20-24). These in turn need to be
correlated with rheological behavior (23-25).
Cells of the Respiratory
Epithelium
Within the airway epithelial lining eight epithelial
cell types have now beenidentified (8, 9)(Fig. 1). All
cellstouchthe basementmembrane, only twodo not
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FIGURE 1. Eight epithelial cell types present in rat airway epithe-
lium.
reach the lumen-the basal and Kulschitsky cells.
The serous, Clara and mucous are the secretory cell
types. The undifferentiated or intermediate cell, the
ciliated and brush cells are not secretory. "Mucous"
isthe term we now prefer to goblet cell, since we can
define it by reference to the nature ofthe secretory
granules, whereas "goblet" refers essentially to the
amount and shape of the secretory mass which re-
sembles a chalice or goblet. The serous and Clara
cells are each characterized by electron-dense and
discrete granules: the Clara cell has a considerable
amount of smooth endoplasmic reticulum and its
apex often bulges above the tight junctions with
neighbouring cells. Two mesenchymal cells are
found: the globule leucocyte and the lymphocyte.
Reconstruction of the human submucosal gland
reveals aduct about 1 mm long, lined by theductcell
- a tall cell, packed with mitochondria and reminis-
cent of the striated duct of the salivary gland, save
that it lacks the striations (26). The tubules are lined
by mucous or serous cells, the "serous" regions
being always distal to a "mucous" region, i.e.,
further from airway lumen, and arising either as a
lateral pouch or from the distal ends of a mucous
tubule (Fig. 2) (27).
Nerve fibers are found within the airway epithe-
lium (28). In the rat they are nonmyelinated and only
in the extrapulmonary airways. They are numerous,
particularly in the young animals, and are closely
associated with basal secretory and ciliated cells.
The nature ofthe vesicles they contain suggests that
some are sensory, some motor, and of the latter,
some adrenergic, some cholinergic. Nervefibers are
found within the basement membrane of the sub-
mucosal glands. Myoepithelial cells and "clear"
cells, probably immunoblasts, are also found in the
secretory tubules of the gland.
In the rat, mitotic activity represents turnover of
the airway epithelium that is, in some regions, asfast
as 10 days and in others 250. This range takes into
account all regions, male andfemale, and three ages
(6) (Fig. 3).
Normal Homeostasis
Underbasal conditions, homeostasis oftheairway
epithelium is maintained with regard to several ofits
features, the normal pattern varying from region to
region. The nature ofthe control mechanisms is not
understood. Homeostasis is maintained with respect
to the cell types present. Forexample, inthe trachea
the basal cell is numerous, making up about 30% of
the cell population, whereas it is virtually absent in
peripheral airways; the Clara cell, the secretory cell
of small airways, is not seen in the trachea. Of the
cells that are present, the proportion varies at vari-
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FIGURE 2. Reconstruction of human bronchial gland drawn to
scale, showingcollectingductwith tubulesarisingfromit. The
branching patterns of two tubules arising from the duct are
shown: (-) mucous cells; (- -) serous cells. Secretion from
the serous cell thus passes over the mucous cell before reach-
ing the collecting duct.
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FIGURE 3. Mitotic index (numberofmitotic nuclei per 1000nuclei)
in male and female rats ofthree age groups and at five airway
levels: (levels I-III) proximal, mid- and distal trachea; (level
IV) main intrapulmonary axial pathway, (level V) distal air-
way.
ous airway levels, e.g., the ciliated cell being about 1
in 5 centrally, 2 in 3 peripherally.
At agivenairway level, the pattern ofglycoprotein
within the secretory cells varies (4, 18, 29, 30). The
epithelial glycoprotein is either neutral or acid
(16-18): it is acid either because of sialylation or
sulfation ofthe glycoprotein, and the sialic acid may
or may not be susceptible to digestion by the enzyme
sialidase. Sometimes within a single cell only one
type ofgranule is identified, or there may be a mix-
ture. A cell can be characterized by its predominant
granule type and also by the amount of secretion,
i.e., by the number ofgranules it includes. Regional
differences in the normal pattern of glycoprotein
distribution are also seen.
Cell division is another feature which has a basal
level ofactivity (6). The oldest group of animals we
have studied did not show a regional pattern, in that
the percentage of cells incorporating 3H-thymidine
was similar at all airway levels. Since concentration
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of cells is less in peripheral airways, this means a
slower replacement per unit area in small than in
large airways. In the young animals, in male more
than female, mitotic activity is more marked in the
trachea than in peripheral airways. This sex differ-
ence was apparent in the young animals although
male and female animals were gaining weight at the
same rate.
Homeostasis then is maintained, on a regional
basis, with respect to types of cell present, their
proportion, their rate of mitosis and the pattern of
intracellularglycoprotein identifiedhistochemically.
Analysis of Mucus Secretion,
Cellular Differentiation, and
Their Control
The mucus glycoprotein comes from several cell
types both within the submucosal glands and the
surface epithelium; the mucus is then mixed with
serum components. The structure ofthe airway wall
changes with age and disease. Because of its com-
plexity to understand airway secretion and its con-
trol, we have used amultidisciplinary approachinits
study. Tissue studies of the normal human airway
and ofits modification in hypersecretory statesoffer
an important reference. In organ culture systems of
human airway behavior ofthe various cell types can
be explored and the way their activity is controlled
(31, 32). The total secretion can be analyzed as
sputum and also material collected in organ culture
(11). Environmental conditions can be altered in
animal models. By organ culture of tissue obtained
from such animals in vivo studies can be correlated
with the in vitro (33, 34).
Our more recent organ culture studies of human
epithelium show that secretory cells of the surface
epithelium, at least oflarge airways, unlike the sub-
mucosal glands, are not stimulated to secrete by
acetylcholine orits analogs. 3H-Threonine transport
into mucous and serous cells is largely ouabain-
sensitive, 3H-glucose only partially so. Postpulse
addition of several agents has established that pre-
cursoruptake, glycoprotein synthesisanddischarge,
by mucous and serous cells, are not coupled events
(31). In a series of experiments the effect of col-
chicine and cytochalasin B has been followed (32).
Neither agent influences basal rate of secretion, of
either mucous or serous cell. When incubated with
the tissue and radioactive precursor, both reduce
acetylcholine-stimulated secretion. It seems that the
cytochalasin B-sensitive filament system must be
intactforthe discharge effect ofacholinergic agent.
115ble to identify increase in Alcian Blue staining
granules. When a cell switches to secrete acid glyco-
protein the AB-positive granules appear first at the
40 80 120 160 apex ofthe cell. The "switch-on" ofenzyme respon-
sible for the attachment of sialic acid seems to start
innumber ofsecretory cells in6mmofrattracheal nearthe cell apex afterthe secretion is already pack-
after inhalation oftobacco smoke (tobacco), alone aged in its granules. The shift is first to sialylation
nylmethyloxadiazole (tobacco + PMO), orafterair and then to sulfation. When the latter occurs, the
trol). sulfated granules also appear first at the apex with
sialylatedgranulesbeingpresent nearerthe nucleus.
On studying shorter exposure time, it emerged
ng the Homeostatic thatthislabilityofthecellpopulation,particularlyof
iism its secretory cells, is apparent after only one ex- posure to tobacco smoke (5) (Table 1). In this ex-
-ostatic mechanism is reset to a different periment the response to tobacco smoke was moni-
rariety of stimuli - irritants, infections, tored at intervals up to 14 days. Animals were sac-
rificed 20 hrafterthe lastexposure. Extrapulmonary
and intrapulmonary airways showed different pat-
terns of response. In the case of the trachea, one
ogical response of the epithelium is illus- period ofexposure to tobacco produced adischarge
y its reaction to tobacco smoke (30, 33, effect so that total secretory cell number was re- bwithout the addition of an anti-infiam- duced. One exposure produced tolerance to the dis-
.nt (Fig. 4). Phenylmethyloxadiazole charge effect, so that after two days' exposure the
ie agent illustrated although similar re- secretory cells had increased significantly above
)een produced by phenylbutazone. Rats control values. In the intrapulmonary airways no
ed to a smoke from cigarettes, delivered discharge effect was seen: the one 4-hr exposure
Yht auto-smoker over a period of4 hr. In period significantly increased the secretory cell
periment described, this 4-hr daily ex- numberabove control values. Somefurtherincrease
repeated for 4 days a week for 6 weeks. developed during the second week, when the con-
) produced an increase in the concentra- centration of secretory cells was virtually the same
-retory cells. Phenylmethyloxadiazole as that seen after six weeks' exposure.
rented this in the extrapulmonary airway. In the trachea tolerance to exposure is quickly
If intracellular types of glycoprotein lost. One day's rest from exposure restores tolerance
lift intheirpattern. In the tracheathe shift so that the next exposure produces a discharge ef-
)pulation of cells that contains predomi- fect. Adaptation to the environment is rapid and in a
ral glycoprotein to one that is acid-pro- short space of time the maximal effect is produced.
s shift occurs whether or not PMO is Although tolerance is quickly achieved it seems also is shift ocus whether or not PMOr is a d, that is, whether or not there is an Table 1. Mean number ofsecretory cells in 3 mm of
secretory cell number. From our studies epithelium in control rats and after a single 4 hr period
at this shift can be detected within 24 hr, of inhalation of tobacco smoke.
which makes it the most sensitive marker ofchange
in airway epithelium.
Tobacco also increases mitotic activity. A burst of
mitosis is seen 24 hr after starting exposure to to-
bacco smoke; PMO gives partial protection against
this increase. The increase in secretory cells, par-
ticularly mucous cells, arises, in part, from conver-
sion ofundifferentiated cells to secretory cells, from
new cells that appear as the result of mitosis and
within the secretory cell population, by interconver-
sion of serous or Clara cells to mucous cells. The
interconversion is apparent from cell counts and
from identification of intermediate cell forms (9).
Electron-dense granules become mixed with elec-
tron-lucent granules, until, finally, all are electron-
lucent and confluent. By light microscopy it is possi-
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Level Control Tobacco
I 34 8.2 5 1.9a
II 41 8.1 7 o.9ga
Extrapulmonary
airways
III 64 ± 6.5 53 4.6
IV 27 ± 6.4 64 7.4b
V 6 2.8 17 5.3a
Intrapulmonary
airways
VI 28 6.4 29 9.7
VII 6 2.0 7 0.2
ap < 0.01.
bp <0.05.
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we know thto be quickly lost. The homeostasis mechanism is
reset for each of its features, secretory cell type and
population, mitotic activity and glycoprotein pat-
tern: a regional pattern is still apparent.
The anti-inflammatory agent PMO has modulated
the response - offering protection from some as-
pects of the irritant, not from others; PMO given
alone, by parenteral injection, causes increase in
submucosal gland size. In vitro study ofsubmucosal
gland from these animals shows reduced precursor
uptake, as well as decreased discharge. The animals
who had received tobacco plus PMO showed normal
secretory rate, whereas tobacco alone produces an
increase in secretory rate.
Drugs: /3-Adrenergic Agents,
Isoproterenol, and Salbutamol
We have shown that isoproterenol causes hyper-
trophy of the bronchial submucosal gland and also
increases surface epithelial secretory cell number,
even under germ-free conditions (10, 36-38). It is the
secretory cells producing acid glycoprotein that are
particularly increased in the surface epithelium (Fig.
5). In a recent experiment we have extended these
studies to follow the effect of isoproterenol over
shorter times and at various airway levels and to
compare it with that ofsalbutamol (a nonselective /3
and a selective /82 agonist, respectively) (Fig. 6).
The two drugs produce increase in secretory cell
number, but with striking regional differences. At all
levels both drugs cause a shift to acid glycoprotein
production and this, whether or not secretory cell
number is increased. With respect to secretory cell
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FIGURE 6. Mean number of secretory cells in 3 mm of airway
epithelium of control (CON), isoproterenol-treated (IPR), or
salbutamol-treated (SBM) rats at seven levels: (levels I-III) -
proximal, mid, anddistal tracheawith mainbronchi;(levels IV
and V)proximal and distal region ofmainintrapulmonary axial
pathway; (levels VI and VII) lateral branches 6x injections of
drug or normal saline (controls).
numberthe drugs showdifferent regional specificity.
Isoproterenol causes increase in secretory cell
number at all levels save the midtrachea (so this
pattern is not based on the distribution of nerves).
Salbutamol only produces an increase at the most
proximal tracheal level andthe mostdistal partofthe
axial pathway of left lung. At each level the sal-
butamol effect is less marked than the isoproterenol.
The effect can be detected after one injection of
isoproterenol. These studies also show that the la-
bility of the epithelial cell population is striking and
rapid, and the maximal responseisquicklyachieved.
INTRAPULMONARY AIRWAY - Level IV
CON
33 8 40 19
9 9 37 45
x x x..
................................... IPR I...
..
0 100
FIGURE 5. Percentage of secretory cells containing four types of
glycoproteins in control (CON) and isoproterenol-treated
(IPR) rats. Level III = distal trachea, level IV = proximal
region of intrapulmonary axial pathway.
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Recovery
Afterceasing administration ofthe drug, recovery
has been followed; here also major regional differ-
ences are seen (Fig. 7). In the trachea the secretory
cell concentration returns virtually to normal within
a week or so. In other regions differences persist. In
the main bronchus, even 12 weeks later, the secre-
tory cell number has not returned to normal. At this
level there is a stage when secretory granules are
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FIGURE7. Meannumberofsecretorycells in3 mmofepitheliumin
the uppertracheaand leftmainbronchusofcontrol (CON)and
isoproterenol-treated (IPR) ratsafter single daily injections on
6 consecutive days of either normal saline (controls) or iso-
proterenol (10 mg/100 gbody weight). Numberofcells present
24 hr after the last injection and after periods of I to 12 weeks
recovery.
seen as ghost structures and an irregular mixture of
granules of acid and neutral glycoprotein is seen,
different from the orderly way in which a
"switch-on" to acid glycoprotein occurs. It seems
that the airway does not become tolerant of the
stimulus, the tissue does not adapt permanently,
since on withdrawal ofthe isoproterenol, the airway
reverts to normal. During recovery a greater var-
iance is seen between individual animals inthe same
group than during adaptation to the drug. This is
particularly true of surface epithelium. In the sub-
mucosal gland also, hypertrophy is produced by iso-
proterenol and has been shown to revert to normal
within six weeks (36).
It seems that this pattern of response reflects re-
gional differences in sensitivity, based perhaps on
regional differences in the nature and concentration
of receptors. Since these drugs mimic naturally oc-
curring agents, it could be that the adrenergic sys-
tem, , and probably a, is part ofthe normal control
system. Either way the use of the appropriate
agonists and antagonists offers a way to modulate
secretion, certainly experimentally, and perhaps
clinically also.
Intra- and Extracellular Conditions
The histochemical studies of the glycoprotein
within the cell are ofspecial significance in showing
the shift to increased acidification of the oligosac-
charide side chains, with relative increase in sulfated
forms (Fig. 5) and, within the granules that are only
sialylated, to those in which more ofthe sialic acid is
resistant to sialidase. Understanding of the compo-
sition and structure of bronchial mucus glycopro-
teins (as of other epithelial glycoproteins, e.g., gas-
tric and cervical) is an actively expanding field both
as regards the polypeptide core and the oligosac-
charide side chains (20, 23, 39).
The histochemical shift seen in states ofhyperse-
cretion is associated with the biochemical finding of
increased concentration ofbothN-acetylneuraminic
acid (syn-sialic acid) and sulfate in the oligosac-
charide fraction. Sometimes both occur on the same
chain. The largest chains are usually the most heav-
ily sulfated. It seems that whereas sialic acid is a
terminal sugar, sulfation permits further glycosyla-
tion.
Animal studies reveal the striking lability of the
intact epithelium both as regards its cell mix and its
glycoprotein product. These adjustments occur in
the airway cells whether or not increased mitotic
activity is alV- part of the response to a given
stimulus. The speedofadaptation anditsnatureraise
questions as to the mechanisms of homeostasis re-
sponsible for stability in such a complex population
of cells that yet shows such striking regional varia-
tion. These questions then lead to those concerned
with the basis of the resetting of this regulation by
irritants and drugs. Understanding ofthese changes
canbe expected to indicate what is needed tocontrol
the features ofadaptation that are undesirable clini-
cally.
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